Peter Blume-Jensen
President and CEO at Acrivon Therapeutics · 15 reported transactions in 1 company · latest trade Aug 25, 2026
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +12.0%, S&P 500 +8.9% over the same days.
Their trades
Sold | Aug 25, 2026 | Aug 25, 2026 close $2.18 → Oct 29, 2026 close $1.76. S&P 500 +0.8% over the same days. | ||
Bought | Jan 14, 2026 | Jan 14, 2026 close $1.83 → Oct 29, 2026 close $1.76. S&P 500 +11.9% over the same days. |
$31K
Aug 25, 2026 close $2.18 → Oct 29, 2026 close $1.76. S&P 500 +0.8% over the same days.
BoughtAcrivon Therapeutics
$82.1K
Jan 14, 2026 close $1.83 → Oct 29, 2026 close $1.76. S&P 500 +11.9% over the same days.